NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma

by Concetta Saponaro, Alessandro Vagheggini, Emanuela Scarpi, Matteo Centonze, Ivana Catacchio, Ondina Popescu, Maria Irene Pastena, Francesco Giotta, Nicola Silvestris, Anita Mangia
Published 2018-05-01

miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient Prognosis

by Behzad Mansoori, Nicola Silvestris, Ali Mohammadi, Vahid Khaze, Elham Baghbani, Ahad Mokhtarzadeh, Dariush Shanehbandi, Afshin Derakhshani, Pascal H. G. Duijf, Behzad Baradaran
Published 2021-02-01

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib

by Oronzo Brunetti, Antonio Gnoni, Antonella Licchetta, Vito Longo, Angela Calabrese, Antonella Argentiero, Sabina Delcuratolo, Antonio Giovanni Solimando, Andrea Casadei-Gardini, Nicola Silvestris
Published 2019-10-01

Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research

by Nicola Silvestris, Gennaro Ciliberto, Paolo De Paoli, Giovanni Apolone, Maria Luisa Lavitrano, Marco A. Pierotti, Giorgio Stanta, On the behalf of the “dynamic medicine OECI group”
Published 2017-09-01

Short-Term Variations in Neutrophil-to-Lymphocyte and Urea-to-Creatinine Ratios Anticipate Intensive Care Unit Admission of COVID-19 Patients in the Emergency Department

by Antonio Giovanni Solimando, Antonio Giovanni Solimando, Nicola Susca, Paola Borrelli, Marcella Prete, Gianfranco Lauletta, Fabrizio Pappagallo, Roberta Buono, Gianfranco Inglese, Bianca Maria Forina, Donatello Bochicchio, Martina Capobianco, Valeria Carrieri, Sebastiano Cicco, Patrizia Leone, Nicola Silvestris, Nicola Silvestris, Annalisa Saracino, Roberto Ria, Vito Procacci, Giovanni Migliore, Angelo Vacca, Vito Racanelli
Published 2021-01-01

Carcinogenesis of Pancreatic Adenocarcinoma: Precursor Lesions

by Sabina Delcuratolo, Michele Aieta, Daniele Santini, Patrizia Nardulli, Gianni Simone, Anna Elisabetta Brunetti, Amalia Azzariti, Aldo Scarpa, Antonio Gnoni, Antonella Licchetta, Nicola Silvestris
Published 2013-09-01

The Evolving Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Treatment

by Patrizia Leone, Antonio Giovanni Solimando, Rossella Fasano, Antonella Argentiero, Eleonora Malerba, Alessio Buonavoglia, Luigi Giovanni Lupo, Valli De Re, Nicola Silvestris, Vito Racanelli
Published 2021-05-01

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma

by Giuseppe Di Lernia, Patrizia Leone, Antonio Giovanni Solimando, Alessio Buonavoglia, Ilaria Saltarella, Roberto Ria, Paolo Ditonno, Nicola Silvestris, Lucilla Crudele, Angelo Vacca, Vito Racanelli
Published 2020-02-01

Immune Checkpoint Inhibitors in Colorectal Cancer: Challenges and Future Prospects

by Shima Makaremi, Zahra Asadzadeh, Nima Hemmat, Amir Baghbanzadeh, Alessandro Sgambato, Farid Ghorbaninezhad, Hossein Safarpour, Antonella Argentiero, Oronzo Brunetti, Renato Bernardini, Nicola Silvestris, Behzad Baradaran
Published 2021-08-01

COVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial

by Chiara Agrati, Serena Di Cosimo, Daniela Fenoglio, Daniela Fenoglio, Giovanni Apolone, Fabio Ciceri, Gennaro Ciliberto, Fausto Baldanti, Massimo Costantini, Diana Giannarelli, Giuseppe Ippolito, Franco Locatelli, Alberto Mantovani, Alberto Mantovani, Alberto Mantovani, Aldo Morrone, Fabrizio Tagliavini, Antonio Uccelli, Antonio Uccelli, Pier Luigi Zinzani, Pier Luigi Zinzani, Nicola Silvestris, Nicola Silvestris, Maria Rescigno, Maria Rescigno
Published 2021-08-01

The Latest Findings of PD-1/PD-L1 Inhibitor Application in Gynecologic Cancers

by Omid Kooshkaki, Afshin Derakhshani, Hossein Safarpour, Souzan Najafi, Parviz Vahedi, Oronzo Brunetti, Mitra Torabi, Parisa Lotfinejad, Angelo Virgilio Paradiso, Vito Racanelli, Nicola Silvestris, Behzad Baradaran
Published 2020-07-01

Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic...

by Antonella Argentiero, Simona De Summa, Roberta Di Fonte, Rosa Maria Iacobazzi, Letizia Porcelli, Matteo Da Vià, Oronzo Brunetti, Amalia Azzariti, Nicola Silvestris, Antonio Giovanni Solimando
Published 2019-07-01

CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer

by Letizia Porcelli, Rosa Maria Iacobazzi, Roberta Di Fonte, Simona Serratì, Angelica Intini, Antonio Giovanni Solimando, Oronzo Brunetti, Angela Calabrese, Francesco Leonetti, Amalia Azzariti, Nicola Silvestris
Published 2019-03-01

A scoping review on the potentiality of PD-L1-inhibiting microRNAs in treating colorectal cancer: Toward single-cell sequencing-guided biocompatible-based delivery

by Mahdi Abdoli Shadbad, Zahra Asadzadeh, Afshin Derakhshani, Negar Hosseinkhani, Ahad Mokhtarzadeh, Amir Baghbanzadeh, Khalil Hajiasgharzadeh, Oronzo Brunetti, Antonella Argentiero, Vito Racanelli, Nicola Silvestris, Behzad Baradaran
Published 2021-11-01

Prognostic Role of High-Grade Tumor Budding in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-Analysis with a Focus on Epithelial to Mesenchymal Transition

by Rita T. Lawlor, Nicola Veronese, Alessia Nottegar, Giuseppe Malleo, Lee Smith, Jacopo Demurtas, Liang Cheng, Laura D. Wood, Nicola Silvestris, Roberto Salvia, Aldo Scarpa, Claudio Luchini
Published 2019-01-01

Immune Checkpoints and CAR-T Cells: The Pioneers in Future Cancer Therapies?

by Negar Hosseinkhani, Afshin Derakhshani, Omid Kooshkaki, Mahdi Abdoli Shadbad, Khalil Hajiasgharzadeh, Amir Baghbanzadeh, Hossein Safarpour, Ahad Mokhtarzadeh, Oronzo Brunetti, Simon C. Yue, Nicola Silvestris, Behzad Baradaran
Published 2020-11-01

Targeting TGF-β-Mediated SMAD Signaling Pathway via Novel Recombinant Cytotoxin II: A Potent Protein from <i>Naja naja oxiana</i> Venom in Melanoma

by Afshin Derakhshani, Nicola Silvestris, Nima Hemmat, Zahra Asadzadeh, Mahdi Abdoli Shadbad, Niloufar Sadat Nourbakhsh, Leila Mobasheri, Parviz Vahedi, Morteza Shahmirzaie, Oronzo Brunetti, Hossein Safarpour, Behzad Baradaran
Published 2020-11-01

A moonshot approach toward the management of cancer patients in the COVID-19 time: what have we learned and what could the Italian network of cancer centers (Alliance Against Cance...

by Nicola Silvestris, Giovanni Apolone, Gerardo Botti, Gennaro Ciliberto, Massimo Costantini, Paolo De Paoli, Silvia Franceschi, Giuseppe Opocher, Angelo Paradiso, Paolo Pronzato, Alessandro Sgambato, Ruggero De Maria
Published 2020-06-01

Prognostic Role and Clinical Significance of Tumor-Infiltrating Lymphocyte (TIL) and Programmed Death Ligand 1 (PD-L1) Expression in Triple-Negative Breast Cancer (TNBC): A Systema...

by Parisa Lotfinejad, Mohammad Asghari Jafarabadi, Mahdi Abdoli Shadbad, Tohid Kazemi, Fariba Pashazadeh, Siamak Sandoghchian Shotorbani, Farhad Jadidi Niaragh, Amir Baghbanzadeh, Nafiseh Vahed, Nicola Silvestris, Behzad Baradaran
Published 2020-09-01

A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery

by Mahdi Abdoli Shadbad, Sahar Safaei, Oronzo Brunetti, Afshin Derakhshani, Parisa Lotfinejad, Ahad Mokhtarzadeh, Nima Hemmat, Vito Racanelli, Antonio Giovanni Solimando, Antonella Argentiero, Nicola Silvestris, Behzad Baradaran
Published 2021-08-01